Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;26(1):16-20.
doi: 10.1016/j.nmd.2015.10.012. Epub 2015 Nov 10.

Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1

H Orhan Akman  1 , Yavuz Aykit  2 , Ozge Ceren Amuk  2 , Edoardo Malfatti  3 , Norma B Romero  3 , Maria Antonietta Maioli  4 , Rachele Piras  4 , Salvatore DiMauro  2 , Gianni Marrosu  4
Affiliations

Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1

H Orhan Akman et al. Neuromuscul Disord. 2016 Jan.

Abstract

Five Sardinian patients presented in their 5th or 6th decade with progressive limb girdle muscle weakness but their muscle biopsies showed vacuolar myopathy. The more or less abundant subsarcolemmal and intermyofibrillar vacuoles showed intense, partially α-amylase resistant, PAS-positive deposits consistent with polyglucosan. The recent description of late-onset polyglucosan myopathy has prompted us to find new genetic defects in the gene (GYG1) encoding glycogenin-1, the crucial primer enzyme of glycogen synthesis in muscle. We found a single homozygous intronic mutation harbored by five patients, who, except for two siblings, appear to be unrelated but all five live in central or south Sardinian villages.

Keywords: GYG1; Glycogenin deficiency; Glycogenosis; Polyglucosan myopathy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Muscle MRI from Patient 5 shows fatty replacement at hip level (A), of notably the major gluteus (1) and vastus lateralis (2), and at thigh level (B), of notably the vastus lateralis (2) and the adductor magnus (3).
Fig. 2
Fig. 2
Serial sections of vastus lateralis muscle stained strongly with PAS reaction but incompletely digested by alpha-amylase.
Fig. 3
Fig. 3
Electron microscopy shows presence of subsarcolemmal abnormal glycogen material corresponding to polyglucosan bodies (A). At higher magnification, polyglucosan bodies are composed of poorly organized filamentous material (B).
Fig. 4
Fig. 4
Intronic mutation (c.143 + 3G > C) indicated by arrow causes aberrant splicing of the GYG1 mRNA.
See this image and copyright information in PMC

References

    1. Schochet SS, McCormick WF, Zellweger H. Type IV glycogenosis (amylopectinosis). Light and electron microscopic observations. Arch Pathol. 1970;90:354–363. - PubMed
    1. Robitaille Y, Carpenter S, Karpati G, DiMauro S. A distinct form of adult polyglucosan body diseases with massive involvement of central and peripheral neuronal processes and astrocytes. Brain. 1980;103:315–336. - PubMed
    1. Mochel F, Schiffmann R, Steenweg M, et al. Adult polyglucosan body disease: natural history and key MRI findings. Ann Neurol. 2012;72:433–441. - PMC - PubMed
    1. Sukigara S, Liang W-C, Komaki H, et al. Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgia. Neuromuscul Disord. 2012;22:162–165. - PubMed
    1. Cameron JM, Levandovskiy V, MacKay N, et al. Identification of a novel mutation in GSY1 (muscle-specific glycogen synthase) resulting in sudden cardiac death, that is diagnosable from skin fibroblasts. Mol Genet Metab. 2009;98:378–382. - PubMed

Publication types

Supplementary concepts